There are two other vaccines already available in Canada to protect seniors against severe illness caused by RSV: Arexvy ... "RSV immunizing products are optimally administered just before ...

Pfizer gave little information ... this morning that Arexvy had helped the group deliver an “excellent performance” in 2023, adding that it is planning at least 12 major product launches ...

In its Q3 results, GSK (NYSE:GSK), the first to receive U.S. approval for an RSV vaccine in May 2023, said its Arexvy vaccine added £188M in sales, indicating ~ a 73% YoY drop. The British ...

There are two other vaccines already available in Canada to protect seniors against severe illness caused by RSV: Arexvy, manufactured by GSK, and Abrysvo, made by Pfizer. Earlier this year ...

Health Canada has approved the vaccine, mRESVIA, for the prevention of lower respiratory tract disease in older adults, the company said.

GSK is enlisting the aid of China’s Chongqing Zhifei Biological Products (Zhifei ... also call upon it to help it distribute new shot Arexvy. Herpes zoster vaccine Shingrix for shingles has ...